HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.

Abstract
There is a critical need for compounds that target cell surface integrin receptors for applications in cancer therapy and diagnosis. We used directed evolution to engineer the Ecballium elaterium trypsin inhibitor (EETI-II), a knottin peptide from the squash family of protease inhibitors, as a new class of integrin-binding agents. We generated yeast-displayed libraries of EETI-II by substituting its 6-amino acid trypsin binding loop with 11-amino acid loops containing the Arg-Gly-Asp integrin binding motif and randomized flanking residues. These libraries were screened in a high-throughput manner by fluorescence-activated cell sorting to identify mutants that bound to alpha(v)beta(3) integrin. Select peptides were synthesized and were shown to compete for natural ligand binding to integrin receptors expressed on the surface of U87MG glioblastoma cells with half-maximal inhibitory concentration values of 10-30 nM. Receptor specificity assays demonstrated that engineered knottin peptides bind to both alpha(v)beta(3) and alpha(v)beta(5) integrins with high affinity. Interestingly, we also discovered a peptide that binds with high affinity to alpha(v)beta(3), alpha(v)beta(5), and alpha(5)beta(1) integrins. This finding has important clinical implications because all three of these receptors can be coexpressed on tumors. In addition, we showed that engineered knottin peptides inhibit tumor cell adhesion to the extracellular matrix protein vitronectin, and in some cases fibronectin, depending on their integrin binding specificity. Collectively, these data validate EETI-II as a scaffold for protein engineering, and highlight the development of unique integrin-binding peptides with potential for translational applications in cancer.
AuthorsRichard H Kimura, Aron M Levin, Frank V Cochran, Jennifer R Cochran
JournalProteins (Proteins) Vol. 77 Issue 2 Pg. 359-69 (Nov 01 2009) ISSN: 1097-0134 [Electronic] United States
PMID19452550 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Integrin alpha5beta1
  • Integrin alphaVbeta3
  • Peptide Library
  • Peptides
  • Receptors, Vitronectin
  • Trypsin Inhibitors
  • integrin alphaVbeta5
  • Cystine
Topics
  • Amino Acid Sequence
  • Cell Adhesion (physiology)
  • Cell Line, Tumor
  • Cystine (genetics, metabolism)
  • Directed Molecular Evolution
  • Humans
  • Integrin alpha5beta1 (metabolism)
  • Integrin alphaVbeta3 (metabolism)
  • Molecular Sequence Data
  • Peptide Library
  • Peptides (chemistry, genetics, metabolism)
  • Protein Engineering
  • Receptors, Vitronectin (metabolism)
  • Trypsin Inhibitors (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: